MedPath

Clinical study on the collaborative treatment of Chinese and Western medicine for compliance HIV infected patients

Phase 1
Recruiting
Conditions
Acquired Immune Deficiency Syndrome
Registration Number
ITMCTR2100004922
Lead Sponsor
Sichuan Provincial Administration of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1.They met the diagnostic criteria for HIV infection;
2.After antiviral treatment for at least 48 weeks, HIV RNA > 1000 copies / ml;
3.The compliance of antiviral drugs was less than 80%;
4.Aged 18 to 65 years, regardless of gender;
5.The subjects voluntarily participated and informed consent.

Exclusion Criteria

1.Pregnant or lactating women; Or pregnant women;
2.There were severe organic heart disease and arrhythmia; Abnormal liver and kidney function; Patients with active pulmonary tuberculosis or undergoing antituberculosis treatment; Patients with hematological diseases; Suffering from serious mental and neurological diseases;
3.Patients with tumor;
4.Allergic constitution and allergic to test drugs;
5.Patients with history of alcohol abuse or alcohol dependence syndrome.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.